Market Overview

American Shared Hospital Services Announces Resumption of Proton Therapy Services at Orlando Health

Share:

American Shared Hospital Services (NYSE:AMS) (the "Company"),
a leading provider of turnkey technology solutions for advanced
radiosurgical and radiation therapy services, today announced that
proton therapy treatments have now resumed, following water damage to
its proton therapy system at Orlando Health – UF Health Cancer Center
that occurred on July 28, 2018.

About AMS:

American Shared Hospital Services provides turnkey technology solutions
for advanced radiosurgical and radiation therapy services. AMS is the
world leader in providing Gamma Knife radiosurgery equipment, a
non-invasive treatment for malignant and benign brain tumors, vascular
malformations and trigeminal neuralgia (facial pain). The Company also
offers proton therapy, and the latest IGRT and IMRT systems.

Safe Harbor Statement:

This press release may be deemed to contain certain forward-looking
statements with respect to the financial condition, results of
operations and future plans of American Shared Hospital Services
(including statements regarding the expected continued growth in volume
of the MEVION S250 system, the expansion of the Company's proton therapy
business, the impact of service interruptions and the timing of
treatments by new Gamma Knife systems) which involve risks and
uncertainties including, but not limited to, the risks of variability of
financial results between quarters, the risks of the Gamma Knife and
radiation therapy businesses, the risks of developing The Operating Room
for the 21st Century program, and the risks of the timing, financing,
and operations of the Company's proton therapy business. Further
information on potential factors that could affect the financial
condition, results of operations and future plans of American Shared
Hospital Services is included in the filings of the Company with the
Securities and Exchange Commission, including the Company's Annual
Report on Form 10-K for the year ended December 31, 2017, its quarterly
reports on Form 10-Q for the three months ended March 31, 2018 and the
three-months ended June 30, 2018 and its definitive Proxy Statement for
the Annual Meeting of Shareholders held on June 14, 2018.

View Comments and Join the Discussion!